Guardian Pharmacy Services (NYSE:GRDN) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen lowered shares of Guardian Pharmacy Services (NYSE:GRDN) from a buy rating to a hold rating in a report published on Sunday,Wall Street Zen reports.

A number of other equities research analysts also recently commented on GRDN. Weiss Ratings downgraded Guardian Pharmacy Services from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. KeyCorp initiated coverage on Guardian Pharmacy Services in a research note on Tuesday, September 22nd. They set an “overweight” rating and a $52.00 price target for the company. Oppenheimer raised their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Finally, Truist Financial lifted their price objective on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Nine analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $45.57.

Guardian Pharmacy Services Stock Down 0.0%

Shares of GRDN stock opened at $39.42 on Friday. The stock has a market cap of $1.96 billion, a P/E ratio of 38.28, a PEG ratio of 2.06 and a beta of 0.03. Guardian Pharmacy Services has a 52 week low of $26.34 and a 52 week high of $48.33. The company’s fifty day simple moving average is $40.92 and its two-hundred day simple moving average is $39.97.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.26 by $0.03. The business had revenue of $351.77 million during the quarter, compared to the consensus estimate of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. On average, analysts anticipate that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Nisa Investment Advisors LLC increased its holdings in shares of Guardian Pharmacy Services by 53.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,050 shares of the company’s stock worth $43,000 after buying an additional 366 shares during the last quarter. State of Alaska Department of Revenue raised its position in shares of Guardian Pharmacy Services by 105.9% during the 3rd quarter. State of Alaska Department of Revenue now owns 2,390 shares of the company’s stock valued at $97,000 after buying an additional 1,229 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at about $253,000. Stephens Inc. AR bought a new position in shares of Guardian Pharmacy Services in the 1st quarter valued at about $282,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter valued at about $335,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc is a provider of pharmacy services focused primarily on residents of long-term care and other institutional healthcare settings. Through its network of pharmacies, the company supplies prescription medications and related pharmacy support to assisted living communities, skilled nursing facilities, behavioral health organizations, and other care providers.

The company’s services include medication dispensing and packaging, prescription delivery, medication management, clinical pharmacy support, and technology-enabled tools designed to help caregivers and healthcare professionals manage residents’ medication regimens.